The EEF1E1 Knockout MES-OV Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population derived from the MES-OV human ovarian cancer cell line, engineered for targeted disruption of the EEF1E1 gene. This polyclonal knockout model provides a loss-of-function system to investigate the biological functions of the EEF1E1-encoded p18 subunit of the eukaryotic elongation factor-1 (eEF1) complex. The heterogeneous population retains the genetic background of the parental line while incorporating various CRISPR-induced edits across the cell pool, enabling robust functional studies without clonal selection artifacts.
The parental MES-OV line is a well-characterized human ovarian cancer cell model exhibiting a mesenchymal phenotype, widely utilized to dissect mechanisms of ovarian cancer progression, epithelial-mesenchymal transition, and metastatic dissemination. Its mesenchymal subtype is associated with enhanced invasiveness and chemoresistance, making it particularly relevant for preclinical oncology research. The genetic manipulation of EEF1E1 within this context enables direct interrogation of its role in the pathophysiology of mesenchymal ovarian cancer.
EEF1E1 encodes a non-catalytic subunit of the eEF1 complex, which is essential for translation elongation by delivering aminoacyl-tRNA to the ribosomal A-site. The eEF1 complex comprises multiple subunits, including eEF1A (GTP-dependent aminoacyl-tRNA binding) and eEF1B (nucleotide exchange), with EEF1E1 (also known as eEF1B?? or p18) interacting directly with eEF1B??, eEF1B??, and eEF1B??. EEF1E1 sits downstream of nutrient-sensing pathways such as mTOR signaling and is responsive to growth factor stimulation (e.g., EGF, insulin) and cellular stress conditions including ER stress and hypoxia. Its functional output influences global protein synthesis rates and may modulate the expression of apoptosis regulators like MCL-1. The eEF1 complex also interfaces with the integrated stress response, linking translation control to cell fate decisions.
In the MES-OV mesenchymal ovarian cancer background, disruption of EEF1E1 likely compromises translation elongation efficiency, leading to attenuated protein synthesis and potential shifts in the proteome that affect cell proliferation and survival. Given the reliance of aggressive cancer cells on elevated translation to sustain growth and resist apoptosis, EEF1E1 loss may uncover vulnerabilities related to translation dependency. This model is therefore instrumental for dissecting how translation elongation factors contribute to ovarian cancer maintenance and for identifying therapeutic windows where translation inhibition could be exploited.
Researchers can employ this polyclonal knockout model to examine EEF1E1-dependent translation control using polysome profiling and puromycin incorporation (SUnSET) assays. Western blotting and quantitative proteomics enable assessment of global protein output and the expression of key effectors such as MCL-1. Functional assays including MTT and Annexin V staining can quantify cell viability and apoptosis induction upon EEF1E1 disruption. Moreover, these cells serve as a platform for screening small-molecule translation inhibitors and for transcriptomic analyses (RNA-seq) to define EEF1E1-regulated gene networks in mesenchymal ovarian cancer. For additional information, please contact Ascent Research.
